Jiangsu Biojetay Biotechnology Co., Ltd.

This study tests a new drug called STSA-1301 for people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding. The trial includes healthy volunteers and ITP patients to check safety, how the drug works in the body, and whethe…

This study tests a new drug called STSP-0601 in 40 people with hemophilia A or B who have developed inhibitors (antibodies that block standard treatment). The goal is to see if the drug can effectively stop bleeding episodes within 12 hours. Participants receive multiple doses du…